Scott X. Atwood - Publications

Affiliations: 
2008 University of Oregon, Eugene, OR, United States 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Ally MS, Ransohoff K, Sarin K, Atwood SX, Rezaee M, Bailey-Healy I, Kim J, Beachy PA, Chang AL, Oro A, Tang JY, Colevas AD. Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma. Jama Dermatology. 1-5. PMID 26765315 DOI: 10.1001/Jamadermatol.2015.5473  1
2015 Jaju PD, Nguyen CB, Mah AM, Atwood SX, Li J, Zia A, Chang AL, Oro AE, Tang JY, Lee CS, Sarin KY. Mutations in the Kinetochore Gene KNSTRN in Basal Cell Carcinoma. The Journal of Investigative Dermatology. PMID 26348826 DOI: 10.1038/Jid.2015.339  1
2015 Zhao X, Ponomaryov T, Ornell KJ, Zhou P, Dabral SK, Pak E, Li W, Atwood SX, Whitson RJ, Chang AL, Li J, Oro AE, Chan JA, Kelleher JF, Segal RA. RAS/MAPK activation drives resistance to Smo inhibition, metastasis and tumor evolution in Shh pathway-dependent tumors. Cancer Research. PMID 26130651 DOI: 10.1158/0008-5472.Can-14-2999-T  1
2015 Atwood SX, Sarin KY, Whitson RJ, Li JR, Kim G, Rezaee M, Ally MS, Kim J, Yao C, Chang AL, Oro AE, Tang JY. Smoothened variants explain the majority of drug resistance in basal cell carcinoma. Cancer Cell. 27: 342-53. PMID 25759020 DOI: 10.1016/J.Ccell.2015.02.002  1
2014 Atwood SX, Whitson RJ, Oro AE. Advanced treatment for basal cell carcinomas. Cold Spring Harbor Perspectives in Medicine. 4: a013581. PMID 24985127 DOI: 10.1101/Cshperspect.A013581  1
2014 Tang Y, Gholamin S, Schubert S, Willardson MI, Lee A, Bandopadhayay P, Bergthold G, Masoud S, Nguyen B, Vue N, Balansay B, Yu F, Oh S, Woo P, Chen S, ... ... Atwood SX, et al. Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition. Nature Medicine. 20: 732-40. PMID 24973920 DOI: 10.1038/Nm.3613  1
2014 Chang AL, Atzmon G, Bergman A, Brugmann S, Atwood SX, Chang HY, Barzilai N. Identification of genes promoting skin youthfulness by genome-wide association study. The Journal of Investigative Dermatology. 134: 651-7. PMID 24037343 DOI: 10.1038/Jid.2013.381  1
2013 Atwood SX, Whitson RJ, Oro AE. "Patch"ing up our tumor signaling knowledge. The Journal of Investigative Dermatology. 133: 1131-3. PMID 23594533 DOI: 10.1038/Jid.2012.506  1
2012 Graybill C, Wee B, Atwood SX, Prehoda KE. Partitioning-defective protein 6 (Par-6) activates atypical protein kinase C (aPKC) by pseudosubstrate displacement. The Journal of Biological Chemistry. 287: 21003-11. PMID 22544755 DOI: 10.1074/Jbc.M112.360495  1
2010 Bershteyn M, Atwood SX, Woo WM, Li M, Oro AE. MIM and cortactin antagonism regulates ciliogenesis and hedgehog signaling. Developmental Cell. 19: 270-83. PMID 20708589 DOI: 10.1016/J.Devcel.2010.07.009  1
2009 Atwood SX, Prehoda KE. aPKC phosphorylates Miranda to polarize fate determinants during neuroblast asymmetric cell division. Current Biology : Cb. 19: 723-9. PMID 19375318 DOI: 10.1016/J.Cub.2009.03.056  1
2007 Atwood SX, Chabu C, Penkert RR, Doe CQ, Prehoda KE. Cdc42 acts downstream of Bazooka to regulate neuroblast polarity through Par-6 aPKC. Journal of Cell Science. 120: 3200-6. PMID 17726059 DOI: 10.1242/Jcs.014902  1
Show low-probability matches.